Discontinuation of anticoagulant care during admission to a psychiatric hospitalABDULLAH-KOOLMEES, H; GERBRANDA, T; DENEER, V. H. M et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 1025-1029, issn 0031-6970, 5 p.Article

Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genesTEICHERT, Martina; EIJGELSHEIM, Mark; UITTERLINDEN, Andre G et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 1, pp 26-34, issn 1744-6872, 9 p.Article

Invasive procedures in the outpatient setting : Managing the short-acting acenocoumarol and the long-acting phenprocoumonVAN GEEST-DAALDEROP, Johanna H. H; HUTTEN, Barbara A; PEQUERIAUX, Nathalie C. V et al.Thrombosis and haemostasis. 2007, Vol 98, Num 4, pp 747-755, issn 0340-6245, 9 p.Article

Usefulness of Phenprocoumon for the Treatment of Obstructing Thrombus in Bioprostheses in the Aortic Valve PositionJANDER, Nikolaus; KIENZLE, Rolf-Peter; KAYSER, Gian et al.The American journal of cardiology. 2012, Vol 109, Num 2, pp 257-262, issn 0002-9149, 6 p.Article

Pregnancy outcome after maternal intoxication with phenprocoumonHAUCK, Barbara; ZIMMERMANN, Robert; RINGWALD, Juergen et al.British journal of clinical pharmacology. 2011, Vol 71, Num 1, pp 139-140, issn 0306-5251, 2 p.Article

MORDVERSUCH MIT PHENPROCUMON (MARCUMAR). KRANKENSCHWESTER VERURSACHT "FAMILIAERE BLUTUNGSNEIGUNG". = TENTATIVE DE MEURTRE PAR LA PHENPROCOUMONE (MARCOUMAR). TENDANCE DE L'HEMORRAGIE FAMILIALE PROVOQUEE PAR UNE INFIRMIERESCHNEIDER W; GIRMANN G; LUTHE R et al.1975; DTSCHE MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 37; PP. 1838-1841; BIBL. 17 REF.Article

GLC DETERMINATION OF PLASMA CONCENTRATIONS OF PHENPROCOUMONMIDHA KK; HUBBARD JW; COOPER JK et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 3; PP. 387-391; BIBL. 18 REF.Article

Analysis of pooled plasma samples as a predictor for proving bioequivalence of drugs with a long elimination half-life the example of phenprocoumonGATCHEV, Emil; THYROFF-FRIESINGER, Ursula; BAKRACHEVA, Nina et al.Arzneimittel-Forschung. 2004, Vol 54, Num 10, pp 685-689, issn 0004-4172, 5 p.Article

Identification of cytochromes P₄₅₀ 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitroUFER, Mike; SVENSSON, Jan O; KRAUSZ, Kristopher W et al.European journal of clinical pharmacology. 2004, Vol 60, Num 3, pp 173-182, issn 0031-6970, 10 p.Article

BIOTRANSFORMATION OF PHENPROCOUMON IN THE RATHADDOCK RE; TRAGER WF; POHL LR et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 519-523; BIBL. 20REF.Article

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic dataVAN SCHIE, Rianne M. F; WESSELS, Judith A. M; LE CESSIE, Saskia et al.European heart journal. 2011, Vol 32, Num 15, pp 1909-1917, issn 0195-668X, 9 p.Article

Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failureSCHIMANSKI, Carl C; BURG, Jürgen; MÖHLER, Markus et al.Journal of hepatology. 2004, Vol 41, Num 1, pp 67-74, issn 0168-8278, 8 p.Article

Oral anticoagulation with coumarin derivatives and antiptatetet effects of clopidogrelSIBBING, Dirk; VON BECKERATH, Nicolas; MORATH, Tanja et al.European heart journal. 2010, Vol 31, Num 10, pp 1205-1211, issn 0195-668X, 7 p.Article

Diffuse alveolar hemorrhage with acute respiratory distress syndrome associated with phenprocoumon therapyKLENNER, Anne F; FRIESECKE, Sigrun; SCHÄPER, Christoph et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 8, pp 813-815, issn 0957-5235, 3 p.Article

Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumonVISSER, Loes E; PENNING-VAN BEEST, Fernie J. A; WILSON, J. H. P et al.British journal of clinical pharmacology. 2004, Vol 57, Num 4, pp 522-524, issn 0306-5251, 3 p.Article

COUMARIN-ASSOCIATED HEPATITIS: REPORT OF TWO CASESSLAGBOOM G; LOELIGER EA.1980; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1980; VOL. 140; NO 8; PP. 1028-1029; BIBL. 3 REF.Article

NEUROPATHIE DES NERVUS FEMORALIS ALS KOMPLIKATION BEI ANTIKOAGULANTIENTHERAPIE. = NEUROPATHIE DU NERF FEMORAL, COMPLICATION DU TRAITEMENT ANTICOAGULANTLANGE A.1975; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1975; VOL. 30; NO 22; PP. 1034-1037; ABS. RUSSE ANGL.; BIBL. 8 REF.Article

VERSUCHE ZUR BEEINFLUSSUNG DER METASTASIERUNG AUTOCHTONER HEPATOME BEI RATTEN MIT ANTIKOAGULANTIEN. = ETUDES SUR L'INFLUENCE DES ANTICOAGULANTS SUR LA FORMATION DE METASTASES DES HEPATOMES AUTOCHTONES CHEZ LE RATSCHMAEHL D.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 10; PP. 1621-1623; ABS. ANGL.; BIBL. 12 REF.Article

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and PhenprocoumonVERHOEF, Talitha I; RAGIA, Georgia; REDEKOP, William K et al.The New England journal of medicine. 2013, Vol 369, Num 24, pp 2304-2312, issn 0028-4793, 9 p.Article

Quantifying the Effect of Covariates on Concentrations and Effects of Steady-State Phenprocoumon Using a Population Pharmacokinetic/Pharmacodynamic ModelABDULJALIL, Khaled; LAZAR, Simone; SCHWAB, Matthias et al.Clinical pharmacokinetics. 2013, Vol 52, Num 5, pp 359-371, issn 0312-5963, 13 p.Article

Comparative pharmacokinetics of vitamin K antagonists : Warfarin, phenprocoumon and acenocoumarolUFER, Mike.Clinical pharmacokinetics. 2005, Vol 44, Num 12, pp 1227-1246, issn 0312-5963, 20 p.Article

Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugsBEEST, Fernie J. A. Penning-Van; VAN MEEGEN, Erik; ROSENDAAL, Frits R et al.Clinical pharmacology and therapeutics. 2001, Vol 69, Num 6, pp 451-457, issn 0009-9236Article

THE PLASMA ELIMINATION OF THE ENANTIOMERS OF PHENPROCOUMON IN MANHEWICK DS; SHEPHERD AMM.1976; J. PHARM. PHARMACOL.; G.B.; DA. 1976; VOL. 28; NO 3; PP. 257-258; BIBL. 8 REF.Article

ANTIKOAGULANTIENTHERAPIE UND INTRAKRANIELLE BLUTUNGEN = TRAITEMENT ANTICOAGULANT ET HEMORRAGIES INTRACRANIENNESSAURUGG D; SUMMER K.1973; WIEN. MED. WSCHR.; OESTERR.; DA. 1973; VOL. 123; NO 8; PP. 113-118; BIBL. 25 REF.Serial Issue

INTRAKRANIELLE KOMPLIKATIONEN UNTER DER ANTIKOAGULATIENTHERAPIE = COMPLICATIONS INTRACRANIENNES DU TRAITEMENT ANTICOAGULANTBAUER U; WIECZOREK V; BOCK R et al.1973; DTSCHE GESUNDH.-WES.; DTSCH.; DA. 1973; VOL. 28; NO 8; PP. 360-363; ABS. RUSSE ANGL.; BIBL. 26 REF.Serial Issue